Mutations in WNT1 are a cause of osteogenesis imperfecta

S Fahiminiya, J Majewski, J Mort, P Moffatt… - Journal of medical …, 2013 - jmg.bmj.com
S Fahiminiya, J Majewski, J Mort, P Moffatt, FH Glorieux, F Rauch
Journal of medical genetics, 2013jmg.bmj.com
Background Osteogenesis imperfecta (OI) is a heritable bone fragility disorder that is usually
due to dominant mutations in COL1A1 or COL1A2. Rare recessive forms of OI, caused by
mutations in genes involved in various aspects of bone formation, have been described as
well. Objective To identify the cause of OI in eight children with severe bone fragility and a
clinical diagnosis of OI type IV who had had negative results on COL1A1/COL1A2 Sanger
sequencing. Methods Whole exome sequencing was performed in genomic DNA samples …
Background
Osteogenesis imperfecta (OI) is a heritable bone fragility disorder that is usually due to dominant mutations in COL1A1 or COL1A2. Rare recessive forms of OI, caused by mutations in genes involved in various aspects of bone formation, have been described as well.
Objective
To identify the cause of OI in eight children with severe bone fragility and a clinical diagnosis of OI type IV who had had negative results on COL1A1/COL1A2 Sanger sequencing.
Methods
Whole exome sequencing was performed in genomic DNA samples from all eight individuals.
Results
WNT1 mutations were found in four children from three families. WNT1 was the only gene where mutations were found in all of these four patients. Two siblings from a consanguineous family had a homozygous missense mutation affecting a highly conserved cysteine residue in WNT1 (c.428G>T (p.Cys143Phe)). One girl had a homozygous frameshift deletion (c.287_300del(p.Gln96Profs)). A girl from a third family was compound heterozygous for a frameshift insertion and a missense mutation affecting a conserved amino acid (c.946_949insAACA (p.Ser317Lysfs); c.1063G>T (p.Val355Phe)). All of these children had short stature, low bone density, and severe vertebral compression fractures in addition to multiple long bone fractures in the first years of life. The Wnt signalling pathway is one of the key regulators of osteoblast activity.
Conclusions
Recessive inactivating mutations in WNT1 are a new cause of OI type IV.
jmg.bmj.com